In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Arrow Therapeutics gets £21mm in Series B round

Executive Summary

Arrow Therapeutics Ltd. (anti-infectives) raised £21mm ($35mm) in its Series B round led by Atlas Venture. Additional new investors NIF Ventures, ITX, and Scottish Widows Investment Partnership participated along with return investors GIMV, Alta Partners, 3i, TVM, Unibio, and Northern Venture Managers.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies